Connect with us

Health

Hematopoietic stem cell transplants may provide long-term benefit for people with MS – EurekAlert

A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS)…

Published

on

post featured image

MINNEAPOLIS – A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending